IκB-α Activators are a class of chemical compounds that play a crucial role in regulating cellular responses to inflammatory stimuli. These molecules primarily target IκB-α, which is an inhibitory protein found in the cytoplasm of cells. The function of IκB-α is to keep the nuclear factor kappa B (NF-κB) transcription factor in check. NF-κB is a key player in the transcription of genes involved in immune and inflammatory responses. When cells are exposed to pro-inflammatory signals, such as cytokines or bacterial components, NF-κB is activated and translocates into the nucleus, where it initiates the transcription of various genes that mediate inflammation.
IκB-α activators work by promoting the phosphorylation and subsequent degradation of IκB-α. This process is essential for the release and activation of NF-κB. By targeting IκB-α, these compounds indirectly regulate the inflammatory response by allowing NF-κB to enter the nucleus and induce gene expression. This activation of NF-κB can lead to the production of pro-inflammatory cytokines, chemokines, and other molecules involved in immune responses. The exact mechanisms through which IκB-α activators modulate this process can vary among different compounds within this class. Researchers have been exploring the potential of IκB-α activators for their ability to fine-tune the immune response and can be pivotal in elucidating the underlying molecular mechanisms of inflammation and immunity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
BAY 11-7082 is an inhibitor of IκB-α phosphorylation, which results in the stabilization of IκB-α and prevents its degradation. | ||||||
TPCK | 402-71-1 | sc-201297 | 1 g | $178.00 | 2 | |
TPCK inhibits the activity of proteases known as calpains, which can degrade IκB-α, maintaining higher levels of IκB-α. | ||||||
KB-R7943 MESYLATE | 182004-65-5 | sc-202681 | 10 mg | $157.00 | 4 | |
KB-R7943 MESYLATE is a specific IKK inhibitor that interferes with the activation of IKK, preventing the phosphorylation of IκB-α. | ||||||
IMD 0354 | 978-62-1 | sc-203084 | 5 mg | $199.00 | 3 | |
IMD-0354 is an IKK inhibitor that blocks the phosphorylation of IκB-α, stabilizing IκB-α and inhibiting NF-κB signaling. | ||||||
IKK-2 Inhibitor IV | 507475-17-4 | sc-203083 | 500 µg | $130.00 | 12 | |
IKK-2 Inhibitor IV is an IKK-2 inhibitor that blocks IκB-α phosphorylation, stabilizing IκB-α and inhibiting NF-κB. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $79.00 $300.00 | 32 | |
Parthenolide inhibits the phosphorylation of IκB-α by blocking IKK activity. It is a natural compound with anti-inflammatory properties. | ||||||
BMS-345541 | 445430-58-0 | sc-221741 | 1 mg | $306.00 | 1 | |
BMS-345541 is a highly selective IKK inhibitor that disrupts IKK activity, preventing IκB-α phosphorylation and NF-κB inhibition. | ||||||
Wedelolactone | 524-12-9 | sc-200648 sc-200648A | 1 mg 5 mg | $108.00 $330.00 | 8 | |
Wedelolactone inhibits IKK, reducing IκB-α phosphorylation and protecting it from degradation, leading to NF-κB inhibition. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide inhibits the expression of IKKβ, reducing IκB-α phosphorylation and NF-κB activation. | ||||||